Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Sequeira

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Scientific Reports|May 24, 2023
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastomaLiyen K Kan, Matthew Drill, Padmakrishnan C Jayakrishnan, et al.
BMC Neuroscience|October 1, 2025
Characterisation of the expression of P2X7 receptor, cancer stem cell markers and immunological mediators in human high-grade gliomasLiyen K Kan, Matthew Drill, Andrea Muscat, et al.
Journal of the Neurological Sciences|June 19, 2026
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remissionMeltem Karadeniz, Robb Wesselingh, Padmakrishnan C Jayakrishnan, et al.
Clinical Immunology (Orlando, Fla.)|July 4, 2024
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective studyMastura Monif, Richard P Sequeira, Andrea Muscat, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Scientific Reports|May 24, 2023
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastomaLiyen K Kan, Matthew Drill, Padmakrishnan C Jayakrishnan, et al.
BMC Neuroscience|October 1, 2025
Characterisation of the expression of P2X7 receptor, cancer stem cell markers and immunological mediators in human high-grade gliomasLiyen K Kan, Matthew Drill, Andrea Muscat, et al.
Journal of the Neurological Sciences|June 19, 2026
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remissionMeltem Karadeniz, Robb Wesselingh, Padmakrishnan C Jayakrishnan, et al.
Clinical Immunology (Orlando, Fla.)|July 4, 2024
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective studyMastura Monif, Richard P Sequeira, Andrea Muscat, et al.
Pageof 2